ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST)
Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to gain additional safety information as well as to determine
after the study drug has been given to patients who have undergone total hip replacement
surgery, whether the study drug is effective in preventing late deep vein thrombosis (blood
clots in legs) or pulmonary embolism (blood clots in lungs).